Search Orphan Drug Designations and Approvals
-
Generic Name: | crenolanib |
---|---|
Date Designated: | 10/21/2019 |
Orphan Designation: | Treatment of gastric cancer, including cancer of the gastroesophageal junction |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
AROG Pharmaceuticals, Inc. 5420 LBJ Freeway, Suite 410 Dallas, Texas 75240 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-